What is the best trade option for Niagen Bioscience Inc (NAGE) stock?

Niagen Bioscience Inc [NAGE] stock is trading at $8.45, up 5.62%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The NAGE shares have gain 10.89% over the last week, with a monthly amount glided 27.45%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Niagen Bioscience Inc [NASDAQ: NAGE] stock has seen the most recent analyst activity on August 16, 2022, when Oppenheimer downgraded its rating to a Perform. Previously, B. Riley Securities downgraded its rating to Neutral on August 11, 2022, and dropped its price target to $2.40. On March 08, 2022, ROTH Capital initiated with a Buy rating and assigned a price target of $7 on the stock. Oppenheimer started tracking the stock assigning a Outperform rating and suggested a price target of $6 on October 16, 2019. B. Riley FBR initiated its recommendation with a Buy and recommended $7 as its price target on February 14, 2019. In a note dated September 25, 2017, Ladenburg Thalmann initiated an Buy rating and provided a target price of $7 on this stock.

Niagen Bioscience Inc [NAGE] stock has fluctuated between $2.31 and $9.18 over the past year. Niagen Bioscience Inc [NASDAQ: NAGE] shares were valued at $8.45 at the most recent close of the market.

Analyzing the NAGE fundamentals

Niagen Bioscience Inc [NASDAQ:NAGE] reported sales of 99.60M for the trailing twelve months, which represents a growth of 37.41%. Gross Profit Margin for this corporation currently stands at 0.62% with Operating Profit Margin at 0.08%, Pretax Profit Margin comes in at 0.09%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.13, Equity is 0.24 and Total Capital is 0.15. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.06.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.14 points at the first support level, and at 7.84 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.62, and for the 2nd resistance point, it is at 8.80.

Ratios To Look Out For

For context, Niagen Bioscience Inc’s Current Ratio is 3.57. Also, the Quick Ratio is 3.06, while the Cash Ratio stands at 2.48. Considering the valuation of this stock, the price to sales ratio is 6.60, the price to book ratio is 14.18 and price to earnings (TTM) ratio is 80.25.

Transactions by insiders

Recent insider trading involved Lopez Carlos Luis, SVP, General Counsel, that happened on Mar 07 ’25 when 273.0 shares were purchased. Director, Jaksch Frank L Jr completed a deal on Dec 13 ’24 to sell 37161.0 shares. Meanwhile, affiliate Frank Jaksch Jr. bought 37161.0 shares on Dec 13 ’24.

Related Posts